NCT04726969View on ClinicalTrials.gov

Efficacy and Safety of MOX/ALB Co-administration

PHASE3CompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

September 9, 2021

Study Completion Date

September 9, 2021

Conditions
TrichuriasisAscariasisHookworm Infections
Interventions
DRUG

Moxidectin 2 mg Oral Tablet

Tablets of 2 mg moxidectin

DRUG

Albendazole 400 mg Oral Tablet

Tablets of 400 mg albendazole

DRUG

Ivermectin 3 mg Oral Tablet

Tablets of 3 mg ivermectin

Trial Locations (1)

Unknown

Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS), Abidjan

All Listed Sponsors
collaborator

Centre Suisse de Recherches Scientifiques en Cote d'Ivoire

OTHER

lead

Jennifer Keiser

OTHER